Literature DB >> 10490368

Tissue transglutaminase antibodies in dermatitis herpetiformis.

W M Porter, D J Unsworth, R J Lock, C M Hardman, B S Baker, L Fry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10490368     DOI： 10.1016/s0016-5085(99)70482-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  6 in total

1.  Celiac disease and skin: psoriasis association.

Authors:  L Abenavoli; L Leggio; G Gasbarrini; G Addolorato
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

2.  A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice.

Authors:  Eric Marietta; Kay Black; Michael Camilleri; Patricia Krause; Roy S Rogers; Chella David; Mark R Pittelkow; Joseph A Murray
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 3.  Cutaneous manifestations in celiac disease.

Authors:  L Abenavoli; I Proietti; L Leggio; A Ferrulli; L Vonghia; R Capizzi; M Rotoli; P L Amerio; G Gasbarrini; G Addolorato
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

Review 4.  Newly described clinical and immunopathological feature of dermatitis herpetiformis.

Authors:  Veronica Bonciolini; Diletta Bonciani; Alice Verdelli; Antonietta D'Errico; Emiliano Antiga; Paolo Fabbri; Marzia Caproni
Journal:  Clin Dev Immunol       Date:  2012-06-03

Review 5.  The diagnosis and treatment of dermatitis herpetiformis.

Authors:  Emiliano Antiga; Marzia Caproni
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-05-13

6.  Dermatitis herpetiformis: pathophysiology, clinical presentation, diagnosis and treatment.

Authors:  Marcos Vinícius Clarindo; Adriana Tomazzoni Possebon; Emylle Marlene Soligo; Hirofumi Uyeda; Roseli Terezinha Ruaro; Julio Cesar Empinotti
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.